Healthcare practice strategies for integrating personalized medicine: Management of COVID-19

Wen-Yi Liu; Ching-Wen Chien; Tao-Hsin Tung

doi:10.12998/wjcc.v9.i29.8647

Healthcare practice strategies for integrating personalized medicine: Management of COVID-19

World J Clin Cases. 2021 Oct 16;9(29):8647-8657. doi: 10.12998/wjcc.v9.i29.8647.

Authors

Wen-Yi Liu¹, Ching-Wen Chien², Tao-Hsin Tung³

Affiliations

¹ Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, MD 21205, United States; Shanghai Bluecross Medical Science Institute, Shanghai 201100, Shanghai Province, China.
² Institute for Hospital Management, Tsing Hua University, Shenzhen Campus, Shenzhen 518055, Guangdong Province, China.
³ Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai 317000, Zhejiang Province, China. ch2876@gmail.com.

Abstract

Personalized medicine is the tailor-made clinical treatment to the individual characteristics of each patient. It may be considered an extension of traditional approaches to knowing and treating diseases. Personalized medicine has the potential to change the way of identification and management of health problems. Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the patients' lungs. The first case of pneumonia of unknown cause was reported in Wuhan, China on December 31, 2019. As thus, we are quickly approaching the era of personalized medicine. This review discusses the practices currently used in the management of COVID-19 and how they relate to personalized medicine.

Keywords: COVID-19; Healthcare; Personalized medicine; SARS-CoV-2.

Publication types

Review